Clinical performance of serum isoform [-2]proPSA (p2PSA), and its derivatives %p2PSA and the Prostate Health Index, in men aged <60 years: results from a multicentric European study-Reference-Cited by-同舟云学术

Clinical performance of serum isoform [-2]proPSA (p2PSA), and its derivatives %p2PSA and the Prostate Health Index, in men aged <60 years: results from a multicentric European study

Published:2015-03-26 Issue:6 Volume:115 Page:913-920
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Fossati Nicola¹,Lazzeri Massimo²,Haese Alexander³,McNicholas Thomas⁴^ORCID,de la Taille Alexandre⁵,Buffi Nicolò Maria²,Lughezzani Giovanni²,Gadda Giulio Maria¹,Lista Giuliana¹,Larcher Alessandro¹,Abrate Alberto¹,Mistretta Francesco¹,Bini Vittorio⁶,Redorta Joan Palou⁷,Graefen Markus³,Guazzoni Giorgio²

Affiliation:

1. Department of Urology, San Raffaele Turro; Vita-Salute San Raffaele University; Milan Italy

2. Department of Urology; Humanitas Clinical and Research Center, Humanitas University; Milan Italy

3. Martini-Clinic Prostate Cancer Centre; University Clinic Hamburg; Eppendorf Hamburg Germany

4. South Bedfordshire and Hertfordshire Urological Cancer Centre; Lister Hospital; Stevenage UK

5. Department of Urology; APHP Mondor Hospital; Créteil France

6. Department of Internal Medicine; University of Perugia; Perugia Italy

7. Urological Oncology Section of the Department of Urology and Radiology Department; Fundació Puigvert; Barcelona Spain

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.12718/fullpdf

Reference29 articles.

1. Cancer statistics, 2013;Siegel;CA: A Cancer Journal for Clinicians,2013

2. Screening and prostate-cancer mortality in a randomized european study;Schröder;N Engl J Med,2009

3. Mortality results from a randomized prostate-cancer screening trial;Andriole;N Engl J Med,2009

4. Quality-of-life effects of prostate-specific antigen screening;Heijnsdijk;N Engl J Med,2012

5. Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis;Briganti;Eur Urol,2013

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A meta-analysis for the diagnostic accuracy of SelectMDx in prostate cancer;PLOS ONE;2024-02-08

2. Prostate health index (PHI) as an accurate prostate cancer predictor;Journal of Cancer Research and Clinical Oncology;2023-05-19

3. Comparisons of the diagnostic accuracy across prostate health index, prostate health index density, and percentage free prostate-specific antigen for clinically significant prostate cancer: a prospective diagnostic study;Translational Andrology and Urology;2023-03

4. Urinary extracellular vesicles miRNA—A new era of prostate cancer biomarkers;Frontiers in Genetics;2023-01-20

5. Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia;Scientific Reports;2021-07-23